Replies to post #4 on Candel Therapeutics Inc (CADL)

[axelvento]

this is very interesting: https://www.healthleadersmedia.com/pharma/just-two-years-helm-ceo-paul-peter-tak-transforms-candel-and-cancer-treatment




CAN-2409 is also being evaluated in multiple phase 2 and phase 3 clinical trials for lung, brain, pancreatic, and prostate cancers.

but we will have more new data and a new cohort of 11 patients in December this year."